Compare CMRE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMRE | PAHC |
|---|---|---|
| Founded | 1974 | 1946 |
| Country | Monaco | United States |
| Employees | 1880 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | N/A | 2014 |
| Metric | CMRE | PAHC |
|---|---|---|
| Price | $17.21 | $55.58 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 346.0K | 275.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.62% | 0.87% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ $5.55 | $41.62 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $6.63 | $16.16 |
| 52 Week High | $17.91 | $57.62 |
| Indicator | CMRE | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 59.95 |
| Support Level | $16.15 | $37.09 |
| Resistance Level | $17.65 | $56.64 |
| Average True Range (ATR) | 0.48 | 2.81 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 74.32 | 77.36 |
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.